(Translated by https://www.hiragana.jp/)
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Nature. 2014 Jan 23;505(7484):509-14. doi: 10.1038/nature12940.

Abstract

The pathway causing CD4 T-cell death in HIV-infected hosts remains poorly understood although apoptosis has been proposed as a key mechanism. We now show that caspase-3-mediated apoptosis accounts for the death of only a small fraction of CD4 T cells corresponding to those that are both activated and productively infected. The remaining over 95% of quiescent lymphoid CD4 T cells die by caspase-1-mediated pyroptosis triggered by abortive viral infection. Pyroptosis corresponds to an intensely inflammatory form of programmed cell death in which cytoplasmic contents and pro-inflammatory cytokines, including IL-1βべーた, are released. This death pathway thus links the two signature events in HIV infection-CD4 T-cell depletion and chronic inflammation-and creates a pathogenic vicious cycle in which dying CD4 T cells release inflammatory signals that attract more cells to die. This cycle can be broken by caspase 1 inhibitors shown to be safe in humans, raising the possibility of a new class of 'anti-AIDS' therapeutics targeting the host rather than the virus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-HIV Agents / pharmacology
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / pathology*
  • Caspase 1 / metabolism*
  • Caspase 3 / metabolism
  • Caspase Inhibitors / administration & dosage
  • Caspase Inhibitors / pharmacology
  • Cell Death / drug effects
  • HIV Infections / drug therapy
  • HIV Infections / enzymology
  • HIV Infections / immunology*
  • HIV Infections / pathology*
  • HIV-1 / drug effects
  • HIV-1 / growth & development
  • HIV-1 / pathogenicity*
  • Humans
  • In Vitro Techniques
  • Inflammasomes / immunology
  • Inflammasomes / metabolism
  • Inflammation / complications
  • Inflammation / immunology
  • Inflammation / pathology
  • Inflammation / virology
  • Interleukin-1beta / biosynthesis
  • Interleukin-1beta / metabolism
  • Lymph Nodes / enzymology
  • Male
  • Palatine Tonsil / drug effects
  • Palatine Tonsil / virology
  • Protein Precursors / biosynthesis
  • Spleen / drug effects
  • Spleen / virology
  • Virus Replication

Substances

  • Anti-HIV Agents
  • Caspase Inhibitors
  • Inflammasomes
  • Interleukin-1beta
  • Protein Precursors
  • Caspase 3
  • Caspase 1